C14orf28 Inhibitors
Inhibitors of C14orf28 function by interfering with various signaling pathways and cellular processes that are crucial for its activity. Compounds that target kinase activity are particularly effective, as they can prevent phosphorylation, which is a common regulatory mechanism for protein function. Inhibition of mTOR signaling, for example, would disrupt downstream processes that might be essential for the proper functioning of C14orf28, leading to its decreased activity. Similarly, by hindering the PI3K/AKT pathway, an inhibitor would prevent the activation of a key signaling cascade, decreasing the activity of C14orf28 if it is regulated by this pathway. The MEK/ERK pathway is another common regulatory route for protein function; by blocking MEK, subsequent activation of ERK is prevented, which could lead to decreased activity of C14orf28 if it is a downstream effector. Furthermore, inhibitors that target specific MAPK pathways such as p38 or JNK could diminish C14orf28 activity by preventing the propagation of signals necessary for its function.
Other inhibitors work by disrupting cellular structures or blocking the action of regulatory proteins. For instance, if C14orf28 relies on the integrity of the Golgi apparatus, compounds that disturb this organelle would effectively inhibit its activity. Inhibition of G-protein signaling through interference with the Gs-alpha subunit would also lead to decreased activity of C14orf28 given it is part of the G-protein coupled receptor (GPCR) signaling pathway. Additionally, the blocking of calcium-calmodulin interactions by certain inhibitors would result in the downregulation of C14orf28 assuming it is calcium-dependent.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can decrease the phosphorylation status of various proteins. Given C14orf28 activity is dependent on phosphorylation, staurosporine could lead to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that interferes with downstream signaling pathways. Assuming C14orf28 is involved in mTOR signaling, its functional activity would be inhibited. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that binds to the cytosolic protein cyclophilin, whose complex with calcineurin, is involved in the activation of T-cells. Given C14orf28 is involved in the pathway, its activity would be indirectly inhibited. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that blocks the PI3K/AKT pathway. As C14orf28 is directly or indirectly regulated by PI3K/AKT signaling, its activity would be inhibited. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which subsequently prevents the activation of ERK. Assuming C14orf28's activity is regulated by the MEK/ERK pathway, inhibition of MEK would decrease C14orf28 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that blocks p38-driven cellular responses. Given C14orf28 is involved in the p38 MAPK pathway, its inhibition would lead to decreased C14orf28 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which modulates JNK-dependent cellular processes. Inhibition of JNK would lead to decreased activity of C14orf28 since it is involved in JNK signaling. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A potent and selective inhibitor of Gs-alpha subunit of G-proteins. Given C14orf28 is regulated through G-protein coupled receptor signaling, NF449 would inhibit its activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An agent that disrupts Golgi apparatus structure and function. Assuming C14orf28 relies on proper Golgi apparatus function for its activity, Brefeldin A would inhibit it. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that interferes with calcium-calmodulin-dependent processes. | ||||||